Revance Therapeutics reported $1.35B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 270.65B 15.68B
Aerie Pharmaceuticals AERI:US $ 0.36B 0.08B
ALKERMES ALKS:US 4.89B 0.63B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Cara Therapeutics CARA:US $ 0.49B 0.16B
Coherus Biosciences CHRS:US $ 0.56B 0.44B
Eli Lilly And LLY:US $ 308.07B 35.35B
Endo International Ordinary Shares ENDP:US 0.54B 0.34B
Horizon Pharma HZNP:US 18.34B 5.81B
JAZZ PHA JAZZ:US 9.74B 0.13B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Merk MRK:US $ 230.55B 23.1B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Pacira Pharmaceuticals PCRX:US $ 2.65B 0.77B
Procter & Gamble PG:US $ 344.22B 22.39B
Revance Therapeutics RVNC:US $ 1.4B 0.23B
Supernus Pharmaceuticals SUPN:US $ 1.54B 0.18B
Teva Pharmaceutical Industries TEVA:US 8.48B 1.81B